EpicentRx, Inc.

It has felt lately that there may be not be enough radiopharmaceutical companies to satisfy big pharma’s appetite. First, in December 2023, Eli Lilly and Company purchased POINT Biopharma Global In

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. J&J Inks Partnerships With TRexBio, i2O

In what it says is the largest ever global out-licensing agreement by a Chinese biotech, I-Mab Biopharma Co., Ltd has entered into a global partnership with AbbVie Inc. for a CD47 antibody worth c

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Boehringer, Cipla Ally For Oral Anti-Di